Study To Analyze Memory/Thinking Problems In Older Adults After Surgery

NCT ID: NCT01786577

Last Updated: 2019-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

147 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-03-19

Study Completion Date

2018-07-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to examine specific neuroimaging predictors of memory and executive decline in older adults at various stages after total knee replacement surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cognitive impairment after major cardiac or non-cardiac surgery occurs in a high rate for older adults. The results of previous studies indicate that certain neuro-imaging markers can determine which individuals pose a greater risk for memory and thinking changes after surgery. Based on a pilot study, there is evidence that pre-surgical neuroimaging biomarkers associate with memory and executive decline after a well controlled surgical procedure (total knee antroplasty). In this study, researchers will use brain imaging studies to determine which patients are most likely to be affected by cognitive changes after this type of surgery. The use of Magnetic Resonance Imaging (MRI) will help investigators identify brain biomarkers that are associated with cognitive problems, such as white matter abnormalities and changes to small blood vessels. Patients undergoing total knee replacement surgery, as well as a group of non-surgery participants of similar age, education and health status,will receive cognitive testing and MRI brain scans before and after surgery/non-surgery. Researchers will compare and monitor both groups up to one year after surgery/non-surgery.

Prior to enrollment, participants will be asked to review the informed consent and provide written consent to participate in the study. The enrollment phase will involve in-person baseline assessment of cognitive functioning within two weeks of the scheduled surgery/non-surgery in order to rule out exclusion criteria. Testing will be in cooperation with the University of Florida General Clinical Research Center. Post-baseline MRI will be conducted on all participants (surgery/control) within 48 hours of the surgery/pseudo-surgery date to identify acute stroke differences from baseline. Cognitive assessments will be conducted for each participant at three-weeks, three-months, and one-year after surgery.

The research is highly significant because it will be the first study to use in-vivo diffusion imaging methods to examine the contribution of specific presurgical neuroanatomical vulnerabilities on executive and memory cognitive decline after one of the most common orthopedic surgeries sought by older adults. Additionally, it will be the first study to examine how specific neuroimaging biomarkers interact negatively with specific peri-operative variables including emboli number during surgery, embolic changes to the brain, anesthesia depth, and cerebral oxygenation.

The findings of the study will improve pre-surgery screening procedures for older adults and assist with the development of peri-operative interventions that will prevent neurodegenerative disease acceleration.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Operative Cognitive Decline in Older Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgery

80 patients will undergo total knee replacement surgery; two Magnetic Resonance Imaging scans; cognitive assessment testing.

Magnetic Resonance Imaging

Intervention Type OTHER

Both groups will undergo two MRIs at baseline and within 48 hours after surgery/non-surgery.

Cognitive assessment testing

Intervention Type BEHAVIORAL

Both groups will undergo in-person baseline assessment of cognitive functioning as well as assessments at three weeks, three months and one year.

Non-Surgery

80 non-surgery participants will be included as part of the control group; two Magnetic Resonance Imaging scans; cognitive assessment testing.

Magnetic Resonance Imaging

Intervention Type OTHER

Both groups will undergo two MRIs at baseline and within 48 hours after surgery/non-surgery.

Cognitive assessment testing

Intervention Type BEHAVIORAL

Both groups will undergo in-person baseline assessment of cognitive functioning as well as assessments at three weeks, three months and one year.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic Resonance Imaging

Both groups will undergo two MRIs at baseline and within 48 hours after surgery/non-surgery.

Intervention Type OTHER

Cognitive assessment testing

Both groups will undergo in-person baseline assessment of cognitive functioning as well as assessments at three weeks, three months and one year.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MRI Cognitive assessement tests

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Planned total unilateral knee antroplasty or non-surgical knee osteoarthritis
* Age 60 years or older at the time of baseline assessment
* Telephone screening and in-person baseline cognitive testing not supportive of dementia
* Handedness: Right handed; restriction to left-right hemisphere laterality and white matter pathways
* Participant and family deny presence of difficulties with Instrumental Activities of Daily Living (IADL)
* All ethnic and racial groups will be recruited

Exclusion Criteria

* Underlying medical diseases likely to limit lifespan or confound outcome analyses:

1. cancer requiring treatment in past five years
2. serious infectious diseases
3. congestive heart failure
4. chronic hepatitis
5. history of organ transplantation
6. seizure disorders
7. history of head trauma resulting in intensive care
8. current diagnosis of alcoholism, drug dependence, history of major tranquilizer use
* Neurodegenerative Exclusions:

1. history of major stroke
2. exposure to toxins or neuroleptics
3. history of encephalitis
4. neurological signs of upper motor neuron disease, cerebellar involvement, supranuclear palsy, or significant orthostatic hypertension
5. signs of dementia.
* Psychiatric Exclusions:

1. major psychiatric disorder
2. major depression
* Conditions or behaviors likely to affect imaging or cognitive testing:

1. claustrophobia
2. non-medical bodily metal, pace-maker device
3. less than five years of formal education
4. inability to read or write
5. self-reported hearing difficulty that interferes with standardized test administration
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Institute of Nursing Research (NINR)

NIH

Sponsor Role collaborator

University of Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Catherine Price, Ph.D

Role: PRINCIPAL_INVESTIGATOR

University of Florida

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Florida

Gainesville, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hizel LP, Warner ED, Wiggins ME, Tanner JJ, Parvataneni H, Davis R, Penney DL, Libon DJ, Tighe P, Garvan CW, Price CC. Clock Drawing Performance Slows for Older Adults After Total Knee Replacement Surgery. Anesth Analg. 2019 Jul;129(1):212-219. doi: 10.1213/ANE.0000000000003735.

Reference Type DERIVED
PMID: 30273231 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01NR014181-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

487-2012

Identifier Type: OTHER

Identifier Source: secondary_id

IRB201601040-N

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gerofit and Cognition
NCT06107842 RECRUITING NA
Metacognition in Neurological Injury
NCT03752697 ACTIVE_NOT_RECRUITING
The Neural Substrates for Working Memory Training
NCT03012269 UNKNOWN PHASE2/PHASE3